Back to Top Skip to main content Skip to sub-navigation

Military Health System participating in COVID-19 vaccine trial

Woman measuring out a vaccine into a needle Five military medical treatment facilities are participating in a Phase 3 clinical trial testing a COVID-19 vaccine in development with AstraZeneca. (Photo by Air Force Staff Sgt. Joshua Garcia.)

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit | Vaccine Trials

Five military medical treatment facilities in the National Capital Region, Texas, and California are participating in a phase 3 clinical trial testing the AstraZeneca COVID-19 vaccine in development under Operation Warp Speed.  The DoD sites are actively enrolling study participants, with a goal to recruit up to 1,000 volunteers in each of the three market areas towards the total AstraZeneca clinical trial enrollment of 30,000 people.

Operation Warp Speed, a multiagency U.S. Government effort led by the Department of Health and Human Services and the Department of Defense, is working with the private sector with the aims to deliver safe and effective COVID-19 vaccine doses to the American public beginning January 2021.

OWS is funding clinical trials evaluating several vaccine candidates which were selected based on promising data on safety, immune response, and protection in animal studies and safety and immune response data in early-stage trials in humans. Each of the trials is designed to collect data on how well a vaccine candidate protects against COVID-19 and on the safety of the vaccine candidate in a larger population, including people most at risk.  

“The Department of Defense continues to play a key role in the development of a potential COVID-19 vaccine,” said Thomas McCaffery, assistant secretary of Defense for Health Affairs. “Now that vaccines have passed the first phases of testing for safety, dosing, and response, we have moved into the next phase where volunteers are needed to join large clinical studies. We are excited to have several sites supporting these next steps in the vaccine development process.”

Large phase 3 clinical trials are a necessary part of the rigorous scientific process to test the efficacy and safety of a vaccine in a real-world setting with a large population sample, said Air Force Col (Dr.) Jessica Cowden, chief medical officer of the DoD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnology Vaccine Acceleration Project.

“Phase 3 studies are designed to evaluate if the vaccine can prevent disease in the populations of people that the vaccine is being developed to protect,” said Cowden. “Phase 3 studies are large and usually involve some people who are at risk for infection and disease.”

The National Institute of Allergy and Infectious Diseases at the National Institutes of Health established a network of infectious disease experts and research partners, termed the Coronavirus Prevention Network, or CoVPN, to rapidly and thoroughly evaluate U.S. government-sponsored COVID-19 vaccines. The CoVPN website (https://www.coronaviruspreventionnetwork.org/) provides general information about products being developed to prevent COVID-19 and about clinical trials.

According to the CoVPN, interested volunteers must be adults aged 18 and older to be screened for these initial trials. The CoVPN recognizes the importance of including volunteers who are more likely to get COVID-19, such as those over the age of 65 or with underlying medical conditions; as well as people who work in an essential job, live in a densely populated area, or represent a racial and ethnic group greatly impacted by the epidemic.

Representation by such groups matters in Phase 3 trials because vaccines need to be tested in populations who are at most risk of being exposed to the disease and getting sick in the real world, explained Cowden. “At-risk populations shouldn’t bear a disproportionate burden of research, but they need to be represented,” she said

The selected DoD sites are currently enrolling volunteers for the AstraZeneca clinical trial, according to Cowden. The trial is a randomized control, double-blind study, meaning volunteers will either receive the study vaccine or saline. “The study team and the participant will be blinded so that they won’t know which the participant received until the end of the study,” Cowden said. AstraZeneca’s vaccine candidate is in late-stage clinical trials ongoing in the U.K., Brazil and South Africa.

“Participating in a vaccine clinical trial is voluntary but is also critically vital to ensure that the overall effort is ultimately successful,” said Dr. Sean Biggerstaff, acting deputy director, DHA Research and Development Directorate. “Volunteers should also know safety remains an overriding priority for anyone participating in clinical trials.”

Military health beneficiaries who wish to volunteer for the AstraZeneca COVID-19 vaccine at a nearby military medical treatment facility (or at a civilian site close to home) can contact the local study team directly to request more information or can register on the CoVPN website and consent to be contacted by a research team. If registering on the CoVPN site, interested volunteers should enter the appropriate code in parenthesis from the list below, or enter their ZIP code to join the registry. Site contact information is included here:

At this point, the DoD is only participating in the AstraZeneca study. Additional DoD sites are being prepared for participation in other clinical trials of vaccines and monoclonal antibodies to prevent COVID-19, said Cowden.

“Having a safe and effective COVID-19 vaccine is what we need to protect people and get life back to normal, but in order to get to that point, we have to do these clinical trials,” explained Cowden. “These big Phase 3 clinical trials with a lot of people participating are critical so we can get the information we need to determine if a vaccine candidate is safe and can prevent COVID-19.”

You also may be interested in...

LTG Place Vaccine Roll-Out Video

Video
1/18/2021
DHA Seal

DHA Director LTG Ron Place talks about coronavirus vaccines, their safety and efficacy, and encourages everyone to do their own research to get vaccinated.

Recommended Content:

MHS Toolkits and Branding Guidance | MHS Toolkits and Branding Guidance | Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

MHS Minute: December 2020

Video
12/28/2020
DHA Seal

See how MHS is leading a phased approach to offer 11.1 million Department of Defense personnel the first COVID-19 vaccines. To learn more about the safety and efficacy behind COVID-19 vaccines, go to: https://www.health.mil/Military-Health-Topics/Combat-Support/Public-Health/Coronavirus/COVID-19-Vaccine-Efforts.

Recommended Content:

COVID-19 Vaccine Efforts | Coronavirus | MHS Toolkits and Branding Guidance

MHS COVID Response

Video
12/21/2020
DHA Seal

The men and women of the Military Health System spent 2020 working to protect beneficiaries' health during the coronavirus pandemic. Here are just a few of our accomplishments.

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit | COVID-19 Vaccine Toolkit | COVID-19 Vaccine Efforts

Heroes Behind the Mask

Video
12/17/2020
DHA Seal

A tribute to those across the Military Health System who deserve recognition and thanks for their hard work during this pandemic.

Recommended Content:

Coronavirus | Heroes Behind the Mask | COVID-19 Vaccine Toolkit

COVID-19 Response

Video
12/14/2020
DHA Seal

USPHS Lt. Courtney Labitzky, assigned to the Javits New York Medical Station (JNYMS), talks about their position at JNYMS in support of the Department of Defense COVID-19 response, April 29, 2020. U.S. Northern Command, through U.S. Army North, is providing military support to the Federal Emergency Management Agency to help communities in need. (U.S. Army Video by Cpl. Rachel Thicklin)

Recommended Content:

Heroes Behind the Mask | COVID-19 Vaccine Toolkit

COVID-19 Vaccine Update | How Vaccines are Developed

Video
12/14/2020
COVID-19 Vaccine Update | How Vaccines are Developed

COVID-19 vaccines are within sight in the United States! Scientists continue making progress in testing and monitoring COVID-19 vaccines for safety and effectiveness, and the federal government is ensuring that all adults who want a vaccine will be able to get one at no cost. Learn how these and other vaccines are developed, tested, and authorized for use – and how they work to prevent diseases like COVID-19. This video uses interviews and visuals to help viewers understand the science behind vaccines and why there is reason for optimism. Experts featured in the video include: Dr. Anthony Fauci, National Institutes of Health; Dr, Moncef Slaoui, Operation Warp Speed; Dr. Stephen Hahn, Food and Drug Administration; Dr. Robert Kadlec, Assistant Secretary for Preparedness and Response in the Department of Health and Human Services. For more information, visit http://www.coronavirus.gov.

Recommended Content:

COVID-19 Vaccine Efforts | Immunization Healthcare | COVID-19 Vaccine Toolkit | COVID-19 Vaccine Toolkit

COVID-19 Response2

Video
11/27/2020
DHA Seal

Army Spc. Sean Colangelo, assigned to the Javits New York Medical Station (JNYMS), talks about their position at JNYMS in support of the Department of Defense COVID-19 response, April 23, 2020. U.S. Northern Command, through U.S. Army North, is providing military support to the Federal Emergency Management Agency to help communities in need. (U.S. Army Video by Cpl. Rachel Thicklin)

Recommended Content:

Coronavirus | Heroes Behind the Mask | COVID-19 Vaccine Toolkit

COVID-19 Response

Video
11/27/2020
DHA Seal

Army Pfc. David Alvarado, assigned to the Javits New York Medical Station (JNYMS), talks about their position at JNYMS in support of the Department of Defense COVID-19 response, April 24, 2020. U.S. Northern Command, through U.S. Army North, is providing military support to the Federal Emergency Management Agency to help communities in need. (U.S. Army Video by Cpl. Rachel Thicklin.)

Recommended Content:

Coronavirus | Heroes Behind the Mask | COVID-19 Vaccine Toolkit

How Can Vaccine and Antibody Studies Move So Quickly and Still Be Safe?

Video
11/3/2020
How Can Vaccine and Antibody Studies Move So Quickly and Still Be Safe?

This video provides a detailed overview of the processes that have been implemented to accelerate the pace of the COVID-19 vaccine and antibody studies, and what is being done to assure safety.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | Getting the COVID-19 Vaccine

The Importance of Enrolling Diverse Participants in COVID-19 Studies

Video
11/3/2020
The Importance of Enrolling Diverse Participants in COVID-19 Studies

This video discusses why enrolling diverse participants in COVID-19 studies is critical for ensuring that, when we find a vaccine, we have enough data from populations who are most affected by COVID-19 to determine vaccine safety and efficacy.

Recommended Content:

COVID-19 Vaccine Efforts | Coronavirus | COVID-19 Vaccine Toolkit

MHS Minute: Heroes Behind the Mask

Video
10/8/2020
Image of MHS Minute Carousel

In the face of a global threat, healthcare heroes across the MHS have donned their mask, and served on the front line of the battle against COVID-19. Tune in to this month's "MHS Minute" to learn more!

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit | Heroes Behind the Mask

The Military Health System Celebrates Labor Day

Video
9/4/2020
The Military Health System Celebrates Labor Day

Labor Day pays tribute to the American workforce. This year, we pay tribute to the Military Health System Workforce.

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit

MHS Minute: A Call to Action for Convalescent Plasma Donation

Video
8/24/2020
Image of MHS Minute Carousel

Have you recovered from COVID-19, or tested positive for antibodies? Consider donating convalescent plasma. For eligibility requirements, and to find a donor center near you, go to https://www.militaryblood.dod.mil/Donors/COVID-19andBloodDonation.aspx

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | COVID-19 Vaccine Toolkit | Armed Services Blood Program

Convalescent Plasma Donation PSA featuring Lt. General Place

Video
7/10/2020
Image of Lt. Gen Place

Lt. Gen Place asks servicemembers DoD-wide to consider dontating plasma in the fight against COVID-19.

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | COVID-19 Vaccine Toolkit | Armed Services Blood Program

MHS Minute: DoD Focused on COVID-19 Testing and Treatment

Video
6/25/2020
Image of MHS Minute Carousel

Have you recovered from COVID-19, or tested positive for antibodies? Consider donating convalescent plasma. To learn how, go to https://www.militaryblood.dod.mil/

Recommended Content:

Coronavirus | COVID-19 Vaccine Toolkit
<< < 1 2 3 4 5  ... > >> 
Showing results 46 - 60 Page 4 of 6

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.